In the spring of 1957, American microbiologist Maurice Hilleman read an article in The New York Times that left him greatly alarmed. “It said that there were all these children taken into dispensaries in Hong Kong, twenty thousand people lined up,” he said, describing the hospital scene in China in an interview years later. “My…
New polices, including testing for hepatitis C virus (HCV) during pregnancy, may increase HCV identification in the pediatric population by addressing gaps in maternal HCV testing.
Clinician adherence to screening protocols for patients with hepatitis B (HBV), as well as to treatment guidelines for those with hepatitis C virus (HCV) is suboptimal.
For patients with chronic hepatitis C infection, sustained viral response (SVR) rates are similar for those aged 65 years and older and those younger than 65.
In San Francisco, California, researchers found data that showed it was feasible to recruit patients who inject drugs for treatment of hepatitis C with ledipasvir-sofosbuvir for 8 weeks.
Rates of HCV infection are much higher among women with opioid use disorder
The FDA has granted Breakthrough Therapy designation to peginterferon lambda (Lambda; Eiger BioPharmaceuticals) for the treatment of hepatitis delta virus (HDV) infection.
The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide Protocol, and Water Purification Solution due to numerous reports of significant health issues.
The United States Preventative Service Task Force has issued a statement that reaffirms its 2009 recommendations for screening pregnant women for hepatitis B virus.
The AGA present an updated summary of best practice advice for surveillance of hepatocellular cancer and DAA therapy timing.
